Literature DB >> 12036057

Comparison of the apoptosis-inducing abilities of various protein synthesis inhibitors in U937 cells.

Ai Kageyama1, Izumi Kusano, Tadashi Tamura, Tatsuya Oda, Tsuyoshi Muramatsu.   

Abstract

We compared the abilities of ricin, diphtheria toxin, cycloheximide, and anisomycin to induce apoptosis, using human myeloid leukemia U937 cells at the concentration of each toxin at which almost complete protein synthesis inhibition was attained within 3 h. Among these toxins, anisomycin was found to be the most potent apoptosis inducer. After a 6-h exposure to anisomycin (1 microg/ml), nearly 95% of the cells had apoptotic nuclear morphological changes, while 53%, 30%, and 10% of the cells showed apoptotic changes after exposure to ricin (0.1 microg/ml), diphtheria toxin (10 microg/ml), and cycloheximide (10 microg/ml), respectively. Furthermore, a rapid increase in caspase-3-like activity was observed in anisomycin-treated cells. A similar increase in caspase-3-like activity was also observed in ricin-treated cells on a slower time schedule. However, only a slight increase in the protease activity was induced by diphtheria toxin or cycloheximide even after 6 h of incubation. Since both ricin and anisomycin are known to act on 28S ribosomal RNA, our results suggest that this action mechanism may be responsible for their potent apoptosis induction, and protein synthesis inhibition alone is not sufficient to induce apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036057     DOI: 10.1271/bbb.66.835

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  8 in total

1.  Role of apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine macrophages.

Authors:  Veselina Korcheva; John Wong; Meghan Lindauer; David B Jacoby; Mihail S Iordanov; Bruce Magun
Journal:  Mol Immunol       Date:  2007-01-25       Impact factor: 4.407

Review 2.  The substrate for long-lasting memory: if not protein synthesis, then what?

Authors:  Aryeh Routtenberg
Journal:  Neurobiol Learn Mem       Date:  2007-12-26       Impact factor: 2.877

3.  Corticobasal ganglia projecting neurons are required for juvenile vocal learning but not for adult vocal plasticity in songbirds.

Authors:  Miguel Sánchez-Valpuesta; Yumeno Suzuki; Yukino Shibata; Noriyuki Toji; Yu Ji; Nasiba Afrin; Chinweike Norman Asogwa; Ippei Kojima; Daisuke Mizuguchi; Satoshi Kojima; Kazuo Okanoya; Haruo Okado; Kenta Kobayashi; Kazuhiro Wada
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-21       Impact factor: 11.205

4.  EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins.

Authors:  Henrick Horita; Jacqueline Thorburn; Arthur E Frankel; Andrew Thorburn
Journal:  J Neurooncol       Date:  2009-05-17       Impact factor: 4.130

5.  A relatively low level of ribosome depurination by mutant forms of ricin toxin A chain can trigger protein synthesis inhibition, cell signaling and apoptosis in mammalian cells.

Authors:  Amanda E Jetzt; Ju-Shun Cheng; Xiao-Ping Li; Nilgun E Tumer; Wendie S Cohick
Journal:  Int J Biochem Cell Biol       Date:  2012-09-12       Impact factor: 5.085

6.  A novel role of cytosolic protein synthesis inhibition in aminoglycoside ototoxicity.

Authors:  Shimon P Francis; Joshua Katz; Kathryn D Fanning; Kimberly A Harris; Brian D Nicholas; Michael Lacy; James Pagana; Paul F Agris; Jung-Bum Shin
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

7.  Ricin A Chain from Ricinus sanguineus: DNA sequence, structure and toxicity.

Authors:  N El-Nikhely; M Helmy; H M Saeed; L A Abou Shama; Z Abd El-Rahman
Journal:  Protein J       Date:  2007-10       Impact factor: 2.371

8.  Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity.

Authors:  Brian D Nicholas; Shimon Francis; Elizabeth L Wagner; Sibo Zhang; Jung-Bum Shin
Journal:  Front Cell Neurosci       Date:  2017-09-27       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.